You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

CHOLESTYRAMINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Cholestyramine patents expire, and what generic alternatives are available?

Cholestyramine is a drug marketed by Ajanta Pharma Ltd, Alkem Labs Ltd, Ani Pharms, Endo Operations, Epic Pharma Llc, Ivax Sub Teva Pharms, Tagi, Teva, Upsher Smith Labs, Zydus Pharms, and Teva Pharms. and is included in seventeen NDAs.

The generic ingredient in CHOLESTYRAMINE is cholestyramine. There are eight drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the cholestyramine profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Cholestyramine

A generic version of CHOLESTYRAMINE was approved as cholestyramine by EPIC PHARMA LLC on August 15th, 1996.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CHOLESTYRAMINE?
  • What are the global sales for CHOLESTYRAMINE?
  • What is Average Wholesale Price for CHOLESTYRAMINE?
Drug patent expirations by year for CHOLESTYRAMINE
Drug Prices for CHOLESTYRAMINE

See drug prices for CHOLESTYRAMINE

Recent Clinical Trials for CHOLESTYRAMINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Centre Hospitalier Universitaire de NiceN/A
Loxo Oncology, Inc.Phase 1
Eli Lilly and CompanyPhase 1

See all CHOLESTYRAMINE clinical trials

Pharmacology for CHOLESTYRAMINE
Drug ClassBile Acid Sequestrant
Mechanism of ActionBile-acid Binding Activity

US Patents and Regulatory Information for CHOLESTYRAMINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms CHOLESTYRAMINE LIGHT cholestyramine POWDER;ORAL 202902-001 Apr 25, 2017 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva CHOLESTYRAMINE LIGHT cholestyramine POWDER;ORAL 074348-001 May 28, 1998 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva CHOLESTYRAMINE LIGHT cholestyramine POWDER;ORAL 074348-002 May 28, 1998 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.